Zotizalkib is a chemical compound that functions as an anaplastic lymphoma kinase (ALK) inhibitor. It is designed for use as a pharmaceutical raw material in the manufacturing of research compounds targeting ALK-driven pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2648641-36-3
Suzetrigine
pharmaceutical raw material
Apalutamide Dithio Impurity
pharmaceutical raw material
Fosaprepitant dimeglumine
pharmaceutical raw material
Calcium mefolinate
pharmaceutical raw material
(18S)-18-(difluoromethyl)-13-fluoro-7,7-dimethyl-9,20-dioxa-1,2,6,17,23-pentazapentacyclo[19.3.1.04,24.010,15.017,22]pentacosa-2,4(24),10(15),11,13,21(25),22-heptaen-5-one
ILAMRXVQSGVCJX-AWEZNQCLSA-N
CC1(COC2=C(CN3[C@@H](COC4=CN5C(=C(C=N5)C(=O)N1)N=C43)C(F)F)C=C(C=C2)F)C